What is the ROE (Return on Equity) of Bruker this year?
The ROE of Bruker this year is 0.31 undefined.
Bruker ROE 2024
Bruker ROE
0.31
Ticker
BRKR
ISIN
US1167941087
WKN
813534
In 2024, Bruker's return on equity (ROE) was 0.31, a 16.49% increase from the 0.27 ROE in the previous year.
Bruker Aktienanalyse
What does Bruker do?
The Bruker Corporation is a leading manufacturer of scientific instruments and solutions for the life science, pharmaceutical, biotech, forensic, clinical, and chemical industries. The company was founded in 1960 and is headquartered in Billerica, Massachusetts, USA. Bruker is divided into four main business segments: Scientific Instruments, Energy and Supercon Technologies, Optics, and Advanced Systems. The products and solutions are used in research, development, and industrial processes in more than 100 countries worldwide. The Scientific Instruments segment offers a wide range of analytical instruments, including X-ray spectroscopy, mass spectrometry, infrared spectroscopy, NMR, microtomography, and electron microscopy, as well as automated laboratory equipment. These instruments are used to investigate and analyze materials, processes, and organisms to gain insights into molecular, atomic, and microscopic connections. The Energy and Supercon Technologies segment is involved in the research and development of innovative technologies and products that contribute to energy generation, transmission, and storage. This includes superconducting magnets, magnetic resonance imaging systems, and NMR spectrometers combined with high-field magnet systems. In the Optics segment, Bruker develops and manufactures optical technologies and components for applications in the life science, microelectronics, semiconductor, military, and aerospace industries. The products range from high-performance microscopes and spectrometers to laser interferometry systems. In the Advanced Systems segment, Bruker offers automated system solutions for semiconductor manufacturing, microelectronics, food technology, and clinical laboratories, which increase production efficiency, save resources, and improve product quality. The systems can range from handling robots to process control systems and quality inspection solutions. Bruker's products have a central role in research, development, and manufacturing of drugs and medical devices, as well as in material and environmental analysis and other application areas. The company's focus is on the research and development of innovative technologies and products for the future. In recent years, Bruker has also invested in the field of artificial intelligence (AI) and machine learning algorithms to further improve the analysis and data evaluation of experimental results. Thanks to these advancements, Bruker is able to be a pioneer in the research and development of cutting-edge applications and solutions. Overall, Bruker is an important player in the analytical instrument industry with a wide range of products that are used worldwide in a large number of application areas. The company provides innovative solutions for a wide range of scientific and industrial needs and drives continuous progress in various industries. Bruker ist eines der beliebtesten Unternehmen auf Eulerpool.com.ROE Details
Decoding Bruker's Return on Equity (ROE)
Bruker's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.
Year-to-Year Comparison
Analyzing Bruker's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.
Impact on Investments
Bruker's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.
Interpreting ROE Fluctuations
Changes in Bruker’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.
Frequently Asked Questions about Bruker stock
How has the Return on Equity (ROE) of Bruker developed compared to the previous year?
The ROE of Bruker has increased by 16.49% increased compared to the previous year.
What impact does a high ROE (Return on Equity) have on investors of Bruker?
A high ROE indicates that Bruker generates good returns on capital and is successful in monetizing its investments. This is a positive indicator for investors.
What impact does a low ROE (Return on Equity) have on investors of Bruker?
A low ROE can indicate that Bruker is having difficulties monetizing its investments successfully and can be a negative signal for investors.
How does a change in the ROE (Return on Equity) of Bruker affect the company?
A change in ROE (Return on Equity) of Bruker can be an indicator of the financial performance of the company and demonstrate how successful the company is compared to other companies in the same industry.
How to calculate the ROE (Return on Equity) of Bruker?
The ROE (Return on Equity) is calculated by dividing the company's profit by the total equity. The formula is: ROE = Profit / Total equity.
Which factors influence the ROE (Return on Equity) of Bruker?
Some factors that can influence Bruker's Return on Equity (ROE) include the efficiency in using equity, the profitability of the company, and the financing structure.
What strategic measures can take to improve the ROE (Return on Equity)?
To improve the Return on Equity (ROE), can take measures such as cost savings, increasing revenue, improving efficiency in the use of equity, and making changes in the financing structure. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to improve ROE.
How much dividend does Bruker pay?
Over the past 12 months, Bruker paid a dividend of 0.2 USD . This corresponds to a dividend yield of about 0.31 %. For the coming 12 months, Bruker is expected to pay a dividend of 0.25 USD.
What is the dividend yield of Bruker?
The current dividend yield of Bruker is 0.31 %.
When does Bruker pay dividends?
Bruker pays a quarterly dividend. This is distributed in the months of December, March, July, September.
How secure is the dividend of Bruker?
Bruker paid dividends every year for the past 13 years.
What is the dividend of Bruker?
For the upcoming 12 months, dividends amounting to 0.25 USD are expected. This corresponds to a dividend yield of 0.39 %.
In which sector is Bruker located?
Bruker is assigned to the 'Health' sector.
Wann musste ich die Aktien von Bruker kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Bruker from 9/16/2024 amounting to 0.05 USD, you needed to have the stock in your portfolio before the ex-date on 8/30/2024.
When did Bruker pay the last dividend?
The last dividend was paid out on 9/16/2024.
What was the dividend of Bruker in the year 2023?
In the year 2023, Bruker distributed 0.2 USD as dividends.
In which currency does Bruker pay out the dividend?
The dividends of Bruker are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Bruker stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von Bruker
Our stock analysis for Bruker Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Bruker Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
